Cargando…
Stem cell therapies in cardiac diseases: Current status and future possibilities
Cardiovascular diseases represent the world’s leading cause of death. In this heterogeneous group of diseases, ischemic cardiomyopathies are the most devastating and prevalent, estimated to cause 17.9 million deaths per year. Despite all biomedical efforts, there are no effective treatments that can...
Autores principales: | Kasai-Brunswick, Tais Hanae, Carvalho, Adriana Bastos, Campos de Carvalho, Antonio Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474720/ https://www.ncbi.nlm.nih.gov/pubmed/34630860 http://dx.doi.org/10.4252/wjsc.v13.i9.1231 |
Ejemplares similares
-
Cell-Based Therapies for Heart Failure
por: Campos de Carvalho, Antonio Carlos, et al.
Publicado: (2021) -
Proteomics in the World of Induced Pluripotent Stem Cells
por: Lindoso, Rafael Soares, et al.
Publicado: (2019) -
Hair follicle-derived mesenchymal cells support undifferentiated growth of embryonic stem cells
por: Coelho de Oliveira, Vanessa Carvalho, et al.
Publicado: (2017) -
Modelling premature cardiac aging with induced pluripotent stem cells from a hutchinson-gilford Progeria Syndrome patient
por: Monnerat, Gustavo, et al.
Publicado: (2022) -
Integrin alpha-5 subunit is critical for the early stages of human pluripotent stem cell cardiac differentiation
por: Neiman, Gabriel, et al.
Publicado: (2019)